Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Transgenic Technology: a Validated Approach for Large-Scale Manufacturing

Transgenic technology as a platform for the production of human recombinant therapeutics offers significant advantages with respect to capital expenditure and cost of goods. For the near future, the transgenic production of monoclonal antibodies represents an ideal technology for the basis of a successful biosimilars programme.

By Yann Echelard, William Gavin, Ashley Lawton, Carol Ziomek and Harry Meade at GTC Biotherapeutics Inc (July 2009)

Keywords: Transgenic technology, production, safety, human recominant therapeutics, monoclonal antibodies,

    View full article    |    Back to Bioprocessing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |